Jul 03, 2018 - Merck's (MRK) sBLA looking to expand the label of Keytruda for first-line treatment of metastatic squamous NSCLC gets FDA's priority review. The decision is expected on Oct 30.
Jun 01, 2018 - These two small-cap biotech stocks could be about to make it big.
May 31, 2018 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
May 31, 2018 - The clock is ticking for these biotechs hoping to score key regulatory victories.
May 18, 2018 - AbbVie's top executives answer tough questions about the company's products and pipeline.
May 16, 2018 - A make-it or break-it determination is fast approaching for one tiny clinical-stage company.
May 12, 2018 - This cancer-focused biotech will take plenty of shots on goal in the years ahead.
May 01, 2018 - Incyte Corp. (NASDAQ:INCY)Q1 2018 Earnings CallMay 01, 2018 8:00 am ETExecutivesMichael Charles A. Booth - Incyte Corp.Hervé Hoppenot - Incyte Corp.Barry P. Flannelly - Incyte Corp.Steven H. Stein - I
May 01, 2018 - Incyte (INCY) reported disappointing results for the first quarter wherein the company reported a loss against expectation of earnings and sales too missed estimates.
May 01, 2018 - Incyte reported a loss in the first quarter while sales also beat estimates.